HIGHLIGHTS
- who: Zou00e9 Guillaume et al. from the Universitu00e9 Paris Citu00e9, Inserm, PARCC, Paris, France have published the research: Renal Carcinoma and Angiogenesis: Therapeutic Target and Biomarkers of Response in Current Therapies, in the Journal: Cancers 2022, x of 27/Oct/2022
- what: Considering the regulation of the VEGF-A pathway by the HIF axis, the authors report here the results on the expression of HIF-1u03b1, HIF-2u03b1 and VHL studied by immunohistochemistry in patients with RCC treated with sunitinib . Study, a reduced signature of 35 genes was developed to differentiate ccRCC patients according to . . .
If you want to have access to all the content you need to log in!
Thanks :)
If you don't have an account, you can create one here.